ASCO Presentation Addresses Use of Avatar Mice to Assess Genomics-based Personalized Cancer Treatment Schemes | GenomeWeb

CHICAGO (GenomeWeb News) – A presentation at the annual American Society of Clinical Oncology meeting this weekend addressed the feasibility — and remaining challenges — of using so-called avatar mouse models to assess treatments targeting apparent driver mutations gleaned from cancer genome sequence data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.